Submitted by dcc on Fri, 2021-06-25 11:42 Study Title: Phase 2 Study of Intraventricular Omburtamab-based Radioimmunotherapy for Pediatric Patients with Recurrent Medulloblastoma and EpendymomaCIRB: Pediatric CIRBLead Group: PBTCStatus: ActiveReview Status: Available to Open
